Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids

Elbadawy M, Tanabe K, Yamamoto H, Ishihara Y, Mochizuki M, Abugomaa A, Yamawaki H, Kaneda M, Usui T, Sasaki K.
Front Pharmacol.
14:1243258.
https://pubmed.ncbi.nlm.nih.gov/37900170/
external link
https://www.frontiersin.org/articles/10.3389/fphar.2023.1243258/full
external link